Ser18 and 23 phosphorylation is required for p53-dependent apoptosis and tumor suppression

EMBO Journal

Volumn 25, Issue 11, 2006, Pages 2615-2622

  Chao, Connie ^a   Herr, Deron ^b   Chun, Jerold ^b   Xu, Yang ^a  

^a SECTION OF MOLECULAR BIOLOGY   (United States)

^b SCRIPPS RESEARCH INSTITUTE   (United States)

Author keywords

Apoptosis; Gene expression; Phosphorylation; Tumor suppression

Indexed keywords

ALANINE; PROTEIN P53; SERINE;

AGING; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; B CELL LYMPHOMA; CANCER; CANCER INHIBITION; CARCINOGENESIS; DEVELOPMENTAL DISORDER; FEMALE; GENE LOCUS; INFRARED RADIATION; MALE; MOUSE; MUTATION; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN FUNCTION; SENESCENCE; THYMOCYTE;

ANIMALS; APOPTOSIS; CELL PROLIFERATION; CELLS, CULTURED; DNA DAMAGE; DNA-BINDING PROTEINS; EMBRYO; MALE; MICE; MICE, KNOCKOUT; MUTATION; NEOPLASMS; PHOSPHORYLATION; SERINE; SURVIVAL RATE; THYMUS GLAND; TUMOR SUPPRESSOR PROTEIN P53;

ANIMALIA;

EID: 33745752959     PISSN: 02614189     EISSN: 14602075     Source Type: Journal    
DOI: 10.1038/sj.emboj.7601167     Document Type: Article

References (33)

1. Bischoff F, Yim S, Pathak S, Grant G, Siciliano M, Giovanella B, Strong L, Tainsky M (1990) Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization. Cancer Res 50: 7979-7984
2. Blaschke JAW, Chun J (1998) Programmed cell death is a universal feature of embryonic and postnatal neuroproliferative regions throughout the central nervous system. J Comp Neurol 396: 39-50
3. Blaschke A, Staley K, Chun J (1996) Widespread programmed cell death in proliferative and postmitotic regions of the fetal cerebral cortex. Development 122: 1165-1174
4. Borges HL, Chao C, Xu Y, Linden R, Wang JY (2004) Radiation-induced apoptosis in developing mouse retina exhibits dose-dependent requirement for ATM phosphorylation of p53. Cell Death Differ 11: 494-502
5. Bouffler S, Kemp C, Balmain A, Cox R (1995) Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice. Cancer Res 55: 3883-3889
6. Chao C, Hergenhahn M, Kaeser MD, Wu Z, Saito S, Iggo R, Hollstein M, Appella E, Xu Y (2003) Cell type- and promoter-specific roles of Ser18 phosphorylation in regulating p53 responses. J Biol Chem 278: 41028-41033
7. Chao C, Yang EM, Xu Y (2000) Rescue of defective T cell development and function in Atm-/- mice by a function. J Immunol 164: 345-349
8. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA, Butel JS, Allan B (1992) Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 356: 215-221
9. Dornan D, Wertz I, Shimizu H, Arnott D, Frantz GD, Dowd P, O'Rourke K, Koeppen H, Dixit VM (2004) The ubiquitin ligase COP1 is a critical negative regulator of p53. Nature 429: 86-92
10. Dumaz N, Meek DW (1999) Serine15 phosphorylation stimulates p53 transactivation but does not directly influence interaction with HDM2. EMBO J 18: 7002-7010
11. Frank KM, Sharpless NE, Gao Y, Sekiguchi JM, Ferguson DO, Zhu C, Manis JP, Horner J, DePinho RA, Alt FW (2000) DNA ligase IV deficiency in mice leads to defective neurogenesis and embryonic lethality via the p53 pathway. Mol Cell 5: 993-1002
12. Fukasawa K, Choi T, Kuriyama R, Rulong S, Vande Woude GF (1996) Abnormal centrosome amplification in the absence of p53. Science 271: 1744-1747
13. Gao Y, Ferguson DO, Xie W, Manis JP, Sekiguchi J, Frank KM, Chaudhuri J, Horner J, DePinho RA, Alt FW (2000) Interplay of p53 and DNA-repair protein XRCC4 in tumorigenesis, genomic stability and development. Nature 404: 897-900
14. Haupt Y, Maya R, Kazaz A, Oren M (1997) Mdm2 promotes the rapid degradation of p53. Nature 387: 296-299
15. Hollstein M, Sidransky D, Vogelstein B, Harris CC (1991) p53 mutations in human cancers. Science 253: 49-53
16. Jacks T, Remington L, Williams BO, Schmitt EM, Halachmi S, Bronson RT, Weinberg RA (1994) Tumor spectrum analysis in p53-mutant mice. Curr Biol 4: 1-7
17. Kang J, Ferguson D, Song H, Bassing C, Eckersdorff M, Alt FW, Xu Y (2005) Functional interaction of H2AX, NBS1, and p53 in ATM-dependent DNA damage responses and tumor suppression. Mol Cell Biol 25: 661-670
18. Ko LJ, Prives C (1996) p53: puzzle and paradigm. Genes Dev 10: 1054-1072
19. Kubbutat MH, Jones SN, Vousden KH (1997) Regulation of p53 stability by Mdm2. Nature 387: 299-303
20. Kurz EU, Douglas P, Lees-Miller SP (2004) Doxorubicin activates ATM-dependent phosphorylation of multiple downstream targets in part through the generation of reactive oxygen species. J Biol Chem 279: 53272-53281
21. Lambert PF, Kashanchi F, Radonovich MF, Shiekhattar R, Brady JN (1998) Phosphorylation of p53 Serine 15 increases interaction with CBP. J Biol Chem 273: 33048-33053
22. Leng RP, Lin Y, Ma W, Wu H, Lemmers B, Chung S, Parant JM, Lozano G, Hakem R, Benchimol S (2003) Pirh2, a p53-induced ubiquitin-protein ligase, promotes p53 degradation. Cell 112: 779-791
23. Li Z, Otevrel T, Cheng HL, Seed B, Stamato TD, Taccioli GE, Alt FW (1995) The XRCC4 gene encodes a novel protein involved in DNA double-strand break repair and V(D)J recombination. Cell 83: 1079-1089
24. Liu G, Parant JM, Lang G, Chau P, Chavez-Reyes A, El-Naggar AK, Multani A, Chang S, Lozano G (2004) Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat Genet 36: 63-68
25. MacPherson D, Kim J, Kim T, Rhee BK, Van Oostrom CT, DiTullio RA, Venere M, Halazonetis TD, Bronson R, De Vries A, Fleming M, Jacks T (2004) Defective apoptosis and B-cell lymphomas in mice with p53 point mutation at Ser 23. EMBO J 23: 3689-3699
26. Martinez JD, Craven MT, Joseloff E, Milczarek G, Bowden GT (1997) Regulation of DNA binding and transactivation in p53 by nuclear localization and phosphorylation. Oncogene 14: 2511-2520
27. Saito SI, Goodarzi AA, Higashimoto Y, Noda Y, Lees-Miller SP, Appella E, Anderson CW (2002) ATM mediates phosphorylation at multiple p53 sites, including Ser46, in response to ionizing radiation. J Biol Chem 277: 12491-12494
28. Sluss HK, Jones SN (2003) Analysing p53 tumour suppressor functions in mice. Expert Opin Ther Targets 7: 89-99
29. Wu Z, Earle J, Saito S, Anderson CW, Appella E, Xu Y (2002) Mutation of mouse p53 Ser23 and the response to DNA damage. Mol Cell Biol 22: 2441-2449
30. Xu Y (2003) Regulation of p53 responses by post-translational modifications. Cell Death Differ 10: 400-403
31. Xu Y (2006) DNA damage: a trigger of innate immunity but a requirement for adaptive immune homeostasis. Nat Rev Immnnol 6: 261-270
32. Xu Y, Yang EM, Brugarolas J, Jacks T, Baltimore D (1998) Involvement of p53 and p21 in cellular defects and tumorigenesis in Atm-/- mice. Mol Cell Biol 18: 4385-4390
33. Ye R, Bodero A, Zhou BB, Khanna KK, Lavin MF, Lees-Miller SP (2001) The plant isoflavenoid genistein activates p53 and Chk2 in an ATM-dependent manner. J Biol Chem 276: 4828-4833